The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of Factor V, comprising an antisense strand having a nucleotide sequence which is less that 25 nucleotides in length and which is substantially complementary to at least a part of Factor V. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression of Factor V using the pharmaceutical composition; and methods for inhibiting the expression of Factor V in a cell.
本发明涉及一种双链
核糖核酸(dsRNA),用于抑制因子V的表达,包括一个具有核苷酸序列的反义链,其长度小于25个核苷酸,并且与因子V的至少一部分具有实质上的互补性。本发明还涉及一种药物组合物,包括dsRNA和药用载体;使用该药物组合物治疗因子V表达引起的疾病的方法;以及抑制细胞中因子V表达的方法。